Bio Key International Stock Current Asset
| BKYI Stock | USD 0.76 0.01 1.30% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess BIO Key's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. BIO Key International Company Current Asset Analysis
BIO Key's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current BIO Key Current Asset | 9.88 M |
Most of BIO Key's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIO Key International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
In accordance with the recently published financial statements, BIO Key International has a Current Asset of 9.88 M. This is 99.18% lower than that of the Software sector and 95.07% lower than that of the Information Technology industry. The current asset for all United States stocks is 99.89% higher than that of the company.
BIO Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO Key's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO Key could also be used in its relative valuation, which is a method of valuing BIO Key by comparing valuation metrics of similar companies.BIO Key is currently under evaluation in current asset category among its peers.
BIO Fundamentals
| Return On Equity | -1.12 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (0.71) % | ||||
| Operating Margin | (0.40) % | ||||
| Current Valuation | 3.12 M | ||||
| Shares Outstanding | 6.85 M | ||||
| Shares Owned By Insiders | 15.79 % | ||||
| Shares Owned By Institutions | 8.00 % | ||||
| Number Of Shares Shorted | 127.87 K | ||||
| Price To Earning | (2.55) X | ||||
| Price To Book | 0.70 X | ||||
| Price To Sales | 0.83 X | ||||
| Revenue | 6.93 M | ||||
| Gross Profit | 5.09 M | ||||
| EBITDA | (3.55 M) | ||||
| Net Income | (4.3 M) | ||||
| Cash And Equivalents | 4.89 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 1.78 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.50 X | ||||
| Book Value Per Share | 1.29 X | ||||
| Cash Flow From Operations | (2.91 M) | ||||
| Short Ratio | 0.23 X | ||||
| Earnings Per Share | (1.93) X | ||||
| Target Price | 2.0 | ||||
| Number Of Employees | 41 | ||||
| Beta | 0.35 | ||||
| Market Capitalization | 5.27 M | ||||
| Total Asset | 8.62 M | ||||
| Retained Earnings | (129.31 M) | ||||
| Working Capital | (2.67 M) | ||||
| Current Asset | 9.88 M | ||||
| Current Liabilities | 1.72 M | ||||
| Net Asset | 8.62 M |
About BIO Key Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO Key International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIO Key using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO Key International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out BIO Key Piotroski F Score and BIO Key Altman Z Score analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.